MedTech Atlas helps export teams understand how each country handles registration, what documents are required, which regulator owns the process, and how timing and cost usually behave.
The public library is a reference for enterprise planning. For product-specific regulatory consulting and localization implementation, leave your company, product, and target countries so we can follow up.
Sources: internal research notes and public regulator information.
This is not a generic article site. It combines country-level regulatory reference material with consulting and localization planning for companies preparing multi-country registration.
Country-level device classification, registration pathway, local representative, technical dossier, certificate leverage, labeling, and post-market requirements.
Country-level drug registration routes, CTD/dossier expectations, review procedures, holder duties, GMP/CPP, and pharmacovigilance requirements.
Countries in the same region often share representative, dossier language, certificate leverage, and labeling patterns. Start with the regional pattern, then check country differences.
For a specific product, target-country list, and current approval status, we can help turn reference research into a practical local registration and landing plan.
The library is most useful before a company commits filing budget, local partners, or launch dates. It helps teams frame the right questions before deeper country-specific review.
Teams preparing to enter overseas markets and needing a first-pass comparison of country registration pathways.
Teams checking classification, dossier gaps, certificate reuse, QMS evidence, and post-market obligations.
Teams comparing target markets before choosing distributors, signing local partners, or promising launch timing.
Partners who need to understand local holder duties, import roles, registration ownership, and execution boundaries.
Teams evaluating whether a product line, certificate portfolio, or target company can support multi-country expansion.
Public pages support early planning. Product-specific consulting and localization planning require company, product, and target-country context.
guide lines: devices and drugs
shared pathways by region
native Chinese / English
Country pages help you frame the pathway. A real registration plan still depends on product type, risk class, existing approvals, target countries, local holder model, labeling, and post-market responsibility. Leave the company, product, and target-country information so we can contact you.
Use country pages to understand regulator, pathway, local representative, certificate leverage, dossier, timing, cost, and post-market duties.
The next judgment depends on your product, risk class, intended use, existing approvals, target countries, and local partner model.
Local holder control, labeling language, distributor role, import responsibility, and post-market duties should be designed before filing.
This site is a reference for enterprise planning. For deeper discussion, leave company information, product information, current approvals, and target countries. We will contact you.
Reference pages support planning; final filing and localization decisions should be checked against current regulator guidance and qualified local advice.
Browse the country guides first. When you need a product-specific answer, share your company, product, target countries, and existing certifications so we can contact you.